SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Trump's policy creates a window of opportunity for Israel in AI

Intel says upcoming layoffs will be less than 20,000—but early retirement won’t be an option

How AI agents will transform work — and what humans must do to stay relevant

Intel-backed Ignite DeepTech launches first cohort in Israel

Buzz

Most popular

Daily

Weekly

1

Intel says upcoming layoffs will be less than 20,000—but early retirement won’t be an option

2

Intel’s AI reset highlights hard lessons from Israeli acquisitions

3

Intel cancels Intel Capital spinoff as Lip-Bu Tan shifts to financial discipline

4

Adam Neumann’s Flow raises over $100M at $2.5B valuation

5

Intel-backed Ignite DeepTech launches first cohort in Israel

Eli Lilly

2 stories about Eli Lilly

מטה אלי לילי ב אינדיאנפוליס

1,000% stock increase: The story behind Eli Lilly’s pharmaceutical dominance

14.08.24|Viki Auslender

Beating second-quarter forecasts mainly due to its weight loss and diabetes drugs, Eli Lilly, the company aspiring to be worth a trillion dollars, has invested heavily in innovative developments, becoming the pharmaceutical manufacturer with the highest market value in the world.

מעבדה רפואה 1 זירת הבריאות

Eli Lilly Signs Multi-Year Collaboration with Anima Biotech

23.07.18|Lilach Baumer

Israel-based Anima will receive an upfront payment of $30 million and $14 million for research, but could potentially get as much as $1.05 billion in milestones